NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Enters Consulting Agreement with Creative Capital Media

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into a consulting agreement with Creative Capital Media (“CCM”). Moving forward, CCM, a media and advertising consultancy, will provide communication and awareness services to InMed in North America.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer